Cocaethylene formation in rat, dog, and human hepatic microsomes

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The dog and rat are important animal models for studying the role of cocaethylene in the pharmacodynamic interaction between cocaine and ethanol. In a previous study in our laboratory it was found that a cocaine dose of 3 mg/kg IV and ethanol 1 g/kg IV failed to produce detectable concentrations of cocaethylene in the plasma of dogs. In follow up to this result, the pharmacokinetic disposition of cocaine and cocaethylene in the dog were determined to be similar. These results suggested significant differences between animal and human cocaethylene formation may occur. To test this possibility the in vitro formation of cocaethylene was determined in rat, dog and human hepatic microsomal preparations containing cocaine (0-7 mM) and ethanol (50 mM). Nonlinear least-squares regression was used to estimate Km and Vmax and the results were compared statistically. The mean ± standard deviation for Km and Vmax in the rat, dog and human were 0.53 ± 0.04, 0.97 ± 0.07, and 0.56 ± 0.08 mM, and 390 ± 9, 233 ± 6, and 60 ± 3 pmol/minute/mg protein, respectively. The Km in the dog was significantly greater (p<0.05) than the Km in the rat and human. The Vmax was statistically different among all three species (rat>dog>human; p<0.05). These results demonstrate that cocaethylene formation is greater in dog than human hepatic microsomes, which is in contrast to in vivo studies that appear to show that humans produce more cocaethylene than dogs. It is suggested by the authors that route of cocaine administration may be an important factor in the formation of cocaethylene when cocaine and ethanol are co-administered.

Original languageEnglish (US)
Pages (from-to)2101-2108
Number of pages8
JournalLife Sciences
Volume64
Issue number23
DOIs
StatePublished - Apr 30 1999

Fingerprint

Microsomes
Rats
Cocaine
Dogs
Liver
Ethanol
Animals
Pharmacodynamics
Pharmacokinetics
cocaethylene
Least-Squares Analysis
Animal Models
Plasmas

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Cocaethylene formation in rat, dog, and human hepatic microsomes. / Song, Ning; Parker, Robert; Laizure, Steven.

In: Life Sciences, Vol. 64, No. 23, 30.04.1999, p. 2101-2108.

Research output: Contribution to journalArticle

@article{8855cff2289f41c296567a603318fb93,
title = "Cocaethylene formation in rat, dog, and human hepatic microsomes",
abstract = "The dog and rat are important animal models for studying the role of cocaethylene in the pharmacodynamic interaction between cocaine and ethanol. In a previous study in our laboratory it was found that a cocaine dose of 3 mg/kg IV and ethanol 1 g/kg IV failed to produce detectable concentrations of cocaethylene in the plasma of dogs. In follow up to this result, the pharmacokinetic disposition of cocaine and cocaethylene in the dog were determined to be similar. These results suggested significant differences between animal and human cocaethylene formation may occur. To test this possibility the in vitro formation of cocaethylene was determined in rat, dog and human hepatic microsomal preparations containing cocaine (0-7 mM) and ethanol (50 mM). Nonlinear least-squares regression was used to estimate Km and Vmax and the results were compared statistically. The mean ± standard deviation for Km and Vmax in the rat, dog and human were 0.53 ± 0.04, 0.97 ± 0.07, and 0.56 ± 0.08 mM, and 390 ± 9, 233 ± 6, and 60 ± 3 pmol/minute/mg protein, respectively. The Km in the dog was significantly greater (p<0.05) than the Km in the rat and human. The Vmax was statistically different among all three species (rat>dog>human; p<0.05). These results demonstrate that cocaethylene formation is greater in dog than human hepatic microsomes, which is in contrast to in vivo studies that appear to show that humans produce more cocaethylene than dogs. It is suggested by the authors that route of cocaine administration may be an important factor in the formation of cocaethylene when cocaine and ethanol are co-administered.",
author = "Ning Song and Robert Parker and Steven Laizure",
year = "1999",
month = "4",
day = "30",
doi = "10.1016/S0024-3205(99)00159-9",
language = "English (US)",
volume = "64",
pages = "2101--2108",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "23",

}

TY - JOUR

T1 - Cocaethylene formation in rat, dog, and human hepatic microsomes

AU - Song, Ning

AU - Parker, Robert

AU - Laizure, Steven

PY - 1999/4/30

Y1 - 1999/4/30

N2 - The dog and rat are important animal models for studying the role of cocaethylene in the pharmacodynamic interaction between cocaine and ethanol. In a previous study in our laboratory it was found that a cocaine dose of 3 mg/kg IV and ethanol 1 g/kg IV failed to produce detectable concentrations of cocaethylene in the plasma of dogs. In follow up to this result, the pharmacokinetic disposition of cocaine and cocaethylene in the dog were determined to be similar. These results suggested significant differences between animal and human cocaethylene formation may occur. To test this possibility the in vitro formation of cocaethylene was determined in rat, dog and human hepatic microsomal preparations containing cocaine (0-7 mM) and ethanol (50 mM). Nonlinear least-squares regression was used to estimate Km and Vmax and the results were compared statistically. The mean ± standard deviation for Km and Vmax in the rat, dog and human were 0.53 ± 0.04, 0.97 ± 0.07, and 0.56 ± 0.08 mM, and 390 ± 9, 233 ± 6, and 60 ± 3 pmol/minute/mg protein, respectively. The Km in the dog was significantly greater (p<0.05) than the Km in the rat and human. The Vmax was statistically different among all three species (rat>dog>human; p<0.05). These results demonstrate that cocaethylene formation is greater in dog than human hepatic microsomes, which is in contrast to in vivo studies that appear to show that humans produce more cocaethylene than dogs. It is suggested by the authors that route of cocaine administration may be an important factor in the formation of cocaethylene when cocaine and ethanol are co-administered.

AB - The dog and rat are important animal models for studying the role of cocaethylene in the pharmacodynamic interaction between cocaine and ethanol. In a previous study in our laboratory it was found that a cocaine dose of 3 mg/kg IV and ethanol 1 g/kg IV failed to produce detectable concentrations of cocaethylene in the plasma of dogs. In follow up to this result, the pharmacokinetic disposition of cocaine and cocaethylene in the dog were determined to be similar. These results suggested significant differences between animal and human cocaethylene formation may occur. To test this possibility the in vitro formation of cocaethylene was determined in rat, dog and human hepatic microsomal preparations containing cocaine (0-7 mM) and ethanol (50 mM). Nonlinear least-squares regression was used to estimate Km and Vmax and the results were compared statistically. The mean ± standard deviation for Km and Vmax in the rat, dog and human were 0.53 ± 0.04, 0.97 ± 0.07, and 0.56 ± 0.08 mM, and 390 ± 9, 233 ± 6, and 60 ± 3 pmol/minute/mg protein, respectively. The Km in the dog was significantly greater (p<0.05) than the Km in the rat and human. The Vmax was statistically different among all three species (rat>dog>human; p<0.05). These results demonstrate that cocaethylene formation is greater in dog than human hepatic microsomes, which is in contrast to in vivo studies that appear to show that humans produce more cocaethylene than dogs. It is suggested by the authors that route of cocaine administration may be an important factor in the formation of cocaethylene when cocaine and ethanol are co-administered.

UR - http://www.scopus.com/inward/record.url?scp=0033617182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033617182&partnerID=8YFLogxK

U2 - 10.1016/S0024-3205(99)00159-9

DO - 10.1016/S0024-3205(99)00159-9

M3 - Article

VL - 64

SP - 2101

EP - 2108

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 23

ER -